To confirm the functionality of IGFL2-AS1 requiring its binding to AR mRNA, we constructed ccRCC cell lines stably expressing wild type IGFL2-AS1 or mutated IGFL2-AS1 (mIGFL2-AS1) deficient of AR mRNA binding motif. This evidence concerns the gene AR and nonpapillary renal cell carcinoma.